CMPS COMPASS Pathways Plc - American Depository Shares
COMPASS Pathways Plc - American Depository Shares Hakkında Wikipedia'dan şirket genel bakışı
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Devamını oku
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder (PTSD) New Drug Application (NDA), Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus.
Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wallach's lab is said to have sought patents for over 200 novel compounds as of May 2024.
Compass Pathways switched from being a nonprofit organization to a for-profit company in 2016. The pharmaceutical company has been backed and funded by a number of tech entrepreneurs such as Peter Thiel. The media outlet Sifted remarks that the biotech billionaire Christian Angermayer was instrumental in the founding of Compass Pathways."
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
CMPS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
CMPS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
CMPS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 8 33,3%
- Al 14 58,3%
- Tut 2 8,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
16 analist · 2026-08-16Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-1.88 | $-0.41 | -1.5% |
| 31 Mart 2026 | $0.71 | $-0.39 | 1.1% |
| 31 Aralık 2025 | $-1.00 | $-0.40 | -0.60% |
| 30 Eylül 2025 | $-1.44 | $-0.40 | -1.0% |
| 30 Haziran 2025 | $-0.41 | $-0.44 | 0.03% |
| 31 Mart 2025 | $-0.38 | $-0.48 | 0.10% |
| 31 Aralık 2024 | $-0.63 | $-0.64 | 0.01% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CMPS | $663M | -2.2 | — | — | -524.8% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
| BDRX | — | — | — | — | — | — |
| KNSA | $3.15B | 55.0 | 60.1% | 8.7% | 11.1% | — |
| IMCR | $1.76B | -48.9 | 28.9% | -8.9% | -9.2% | — |
| AUTL | — | -1.8 | 644.9% | -381.4% | -109.6% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $118M | $119M | $88M | $65M | $44M | $23M | |
| SG&A Expense | $61M | $59M | $49M | $45M | $39M | $28M | |
| Operating Expenses | $179M | $178M | $137M | $110M | $83M | $51M | |
| Operating Income | $-179M | $-178M | $-137M | $-110M | $-83M | $-51M | |
| Interest Expense | · | · | $2M | $0 | $0 | · | |
| Interest Income | $7M | $8M | $5M | · | · | · | |
| Other Non-op | $1M | $823.0K | $255.0K | $19M | $12M | $-9M | |
| Pretax Income | $-290M | $-154M | $-118M | $-91M | $-72M | $-60M | |
| Income Tax | $-2M | $2M | $780.0K | $408.0K | $199.0K | $32.0K | |
| Net Income | $-288M | $-155M | $-118M | $-92M | $-72M | $-60M | |
| EPS (Basic) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| EPS (Diluted) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| Shares (Basic) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| Shares (Diluted) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| EBITDA | $-179M | $-178M | $-137M | $-110M | $-83M | · |
Bilanço 22
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $165M | $220M | $143M | $273M | $190M | |
| Prepaid Expense | $42M | $36M | $41M | $48M | $22M | $12M | |
| Other Current Assets | $6M | $4M | $2M | $1M | $1M | $509.0K | |
| Current Assets | $191M | $201M | $261M | $192M | $295M | $202M | |
| PP&E (Net) | · | $189.0K | $423.0K | $617.0K | $398.0K | $245.0K | |
| PP&E (Gross) | · | · | · | $1M | $756.0K | $433.0K | |
| Accum. Depreciation | · | · | · | $530.0K | $358.0K | $188.0K | |
| Other Non-current Assets | $12M | $7M | $7M | $1M | $213.0K | $57.0K | |
| Total Assets | $210M | $214M | $276M | $197M | $301M | $203M | |
| Accounts Payable | $15M | $12M | $6M | $5M | $3M | $3M | |
| Current Liabilities | $248M | $34M | $20M | $16M | $15M | $7M | |
| Capital Leases | $1M | $303.0K | $2M | $418.0K | $1M | · | |
| Total Liabilities | $263M | $59M | $50M | $16M | $16M | $7M | |
| Long-term Debt | $32M | $30M | $29M | $0 | · | · | |
| Total Debt | $32M | $30M | · | · | · | · | |
| Common Stock | $973.0K | $702.0K | $635.0K | · | · | · | |
| Paid-in Capital | $784M | $705M | $622M | $459M | $445M | $279M | |
| Retained Earnings | $-823M | $-535M | $-380M | $-261M | $-170M | $-98M | |
| AOCI | $-15M | $-16M | $-17M | $-17M | $9M | $15M | |
| Stockholders' Equity | $-53M | $155M | $226M | $181M | $284M | $197M | |
| Liabilities + Equity | $210M | $214M | $276M | $197M | $301M | $203M | |
| Shares Outstanding | 96,085,785 | 68,552,215 | 61,943,471 | · | · | · |
Nakit Akışı 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | $242.0K | $330.0K | $175.0K | $112.0K | |
| Stock-based Comp | $14M | $20M | $17M | $13M | $9M | $18M | |
| Deferred Tax | $22.0K | $-437.0K | $-1M | $-1M | $-545.0K | $-221.0K | |
| Other Non-cash | · | · | $5M | $-26M | $-4M | · | |
| Operating Cash Flow | $-157M | $-119M | $-97M | $-105M | $-68M | $-41M | |
| CapEx | · | $0 | $66.0K | $596.0K | $334.0K | $131.0K | |
| Investing Cash Flow | · | $0 | $-64.0K | $-596.0K | $-334.0K | $-628.0K | |
| Debt Issued | · | $0 | $30M | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $30M | · | · | · | |
| Stock Issued | $140M | $26M | $145M | $440.0K | $155M | $0 | |
| Net Stock Activity | $140M | $26M | $145M | $440.0K | $155M | · | |
| Financing Cash Flow | $141M | $64M | $174M | $1M | $157M | $194M | |
| Net Change in Cash | $-15M | $-55M | $77M | $-130M | $83M | $165M | |
| Taxes Paid | $755.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-119M | $-97M | $-106M | $-68M | · | |
| Levered FCF | · | · | $-100M | · | · | · |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -135.8% | -63.4% | -50.1% | -36.7% | -28.4% | · | |
| ROE | -524.8% | -89.2% | -49.5% | -48.7% | -24.3% | · | |
| ROIC | 836.7% | -97.4% | -61.1% | -61.2% | -29.3% | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 | · | |
| Quick Ratio | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 | · | |
| Debt / Equity | -0.6 | 0.2 | · | · | · | · | |
| LT Debt / Equity | -0.3 | 0.2 | · | · | · | · | |
| Interest Coverage | · | · | -62.1 | · | · | · |
Değerleme (TTM) 11
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-288M | $-155M | $-118M | $-92M | $-72M | · | |
| Market Cap | $663M | $259M | · | · | · | · | |
| Enterprise Value | $545M | $124M | · | · | · | · | |
| P/E | -2.2 | -1.6 | -3.8 | -3.7 | -12.3 | · | |
| P/B | -12.5 | 1.7 | · | · | · | · | |
| P / Tangible Book | · | 1.7 | · | · | · | · | |
| P / Cash Flow | -4.2 | -2.2 | · | · | · | · | |
| P / FCF | · | -2.2 | · | · | · | · | |
| EV / EBITDA | -3.0 | -0.7 | · | · | · | · | |
| EV / FCF | · | -1.0 | · | · | · | · | |
| Earnings Yield | -44.6% | -60.9% | -26.5% | -26.9% | -8.1% | · |
Gelir Tablosu 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $26M | $30M | $27M | $30M | $31M | $32M | $33M | $29M | $25M | $27M | $22M | $20M | $19M | $20M | $14M | |
| SG&A Expense | $23M | $16M | $16M | $13M | $13M | $19M | $16M | $15M | $14M | $14M | $11M | $13M | $13M | $13M | $12M | $12M | |
| Operating Expenses | $52M | $43M | $46M | $41M | $43M | $50M | $48M | $48M | $43M | $39M | $38M | $34M | $33M | $32M | $32M | $26M | |
| Operating Income | $-52M | $-43M | $-46M | $-41M | $-43M | $-50M | $-48M | $-48M | $-43M | $-39M | $-38M | $-34M | $-33M | $-32M | $-32M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | · | $0 | $0 | $0 | |
| Interest Income | $4M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $638.0K | · | · | · | |
| Other Non-op | $546.0K | $484.0K | $370.0K | $383.0K | $-176.0K | $803.0K | $337.0K | $191.0K | $167.0K | $128.0K | $-8M | $112.0K | $-11.0K | $8M | $1M | $7M | |
| Pretax Income | $-253M | $91M | $-97M | $-138M | $-38M | $-18M | $-42M | $-38M | $-38M | $-35M | $-32M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| Income Tax | $331.0K | $-11.0K | $-3M | $-230.0K | $137.0K | $354.0K | $1M | $173.0K | $176.0K | $222.0K | $394.0K | $62.0K | $194.0K | $130.0K | $92.0K | $120.0K | |
| Net Income | $-254M | $91M | $-94M | $-138M | $-38M | $-18M | $-43M | $-39M | $-38M | $-35M | $-33M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| EPS (Basic) | $-1.88 | $0.71 | $-1.03 | $-1.44 | $-0.41 | $-0.20 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| EPS (Diluted) | $-1.88 | $-0.30 | $-0.99 | $-1.44 | $-0.41 | $-0.24 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| Shares (Basic) | 135,039,810 | 110,064,581 | -184,367,003 | 95,337,993 | 93,341,594 | 89,192,252 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| Shares (Diluted) | 135,039,810 | 130,266,693 | -193,816,374 | 95,337,993 | 93,341,594 | 98,641,623 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| EBITDA | $-52M | $-43M | · | $-41M | $-43M | $-50M | · | $-48M | $-43M | $-39M | · | $-34M | $-33M | $-32M | · | $-25M |
Bilanço 22
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $433M | $466M | $150M | $186M | $222M | $260M | $165M | $207M | $229M | $263M | $220M | $248M | $148M | $117M | $143M | $173M | |
| Prepaid Expense | $42M | $44M | $42M | $56M | $54M | $45M | $36M | $26M | $36M | $31M | $41M | $36M | $45M | $50M | $48M | $45M | |
| Other Current Assets | $8M | $7M | $6M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $476M | $511M | $191M | $242M | $276M | $305M | $201M | $234M | $265M | $296M | $261M | $285M | $194M | $168M | $192M | $218M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $359.0K | $423.0K | $309.0K | $482.0K | $612.0K | $617.0K | $555.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $395.0K | |
| Other Non-current Assets | $20M | $14M | $12M | $5M | $9M | $8M | $7M | $7M | $6M | $6M | $7M | $6M | $7M | $212.0K | $1M | $299.0K | |
| Total Assets | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Accounts Payable | $12M | $11M | $15M | $5M | $11M | $9M | $12M | $8M | $8M | $9M | $6M | $4M | $2M | $4M | $5M | $20M | |
| Current Liabilities | $367M | $154M | $248M | $197M | $31M | $30M | $34M | $26M | $22M | $19M | $20M | $15M | $13M | $11M | $16M | $30M | |
| Capital Leases | $2M | $779.0K | $1M | $2M | $2M | $259.0K | $303.0K | $459.0K | $799.0K | $1M | $2M | $2M | $3M | $412.0K | $418.0K | $425.0K | |
| Total Liabilities | $420M | $205M | $263M | $218M | $131M | $124M | $59M | $54M | $52M | $50M | $50M | $46M | $43M | $12M | $16M | $30M | |
| Long-term Debt | $51M | $50M | $32M | $31M | $31M | $31M | $30M | $30M | $29M | $29M | $29M | $28M | $28M | · | $0 | · | |
| Total Debt | $51M | $50M | · | $31M | $31M | $31M | · | $28M | · | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $973.0K | $973.0K | $946.0K | $938.0K | $702.0K | $699.0K | $699.0K | $699.0K | $635.0K | · | · | · | · | · | |
| Paid-in Capital | $1.08B | $1.07B | $784M | $781M | $767M | $763M | $705M | $700M | $695M | $690M | $622M | $617M | $496M | $464M | $459M | $455M | |
| Retained Earnings | $-985M | $-731M | $-823M | $-729M | $-591M | $-553M | $-535M | $-491M | $-453M | $-415M | $-380M | $-347M | $-314M | $-285M | $-261M | $-230M | |
| AOCI | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-31M | |
| Stockholders' Equity | $85M | $327M | $-53M | $38M | $163M | $195M | $155M | $193M | $226M | $259M | $226M | $253M | $166M | $162M | $181M | $195M | |
| Liabilities + Equity | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Shares Outstanding | 135,722,306 | 134,923,295 | 96,085,785 | 96,002,044 | 93,586,348 | 92,848,326 | 68,552,215 | 68,409,068 | 68,387,469 | 68,342,534 | 61,943,471 | · | · | · | · | · |
Nakit Akışı 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $59.0K | $63.0K | $61.0K | · | $186.0K | $110.0K | $48.0K | $76.0K | $100.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $9M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-40M | $-48M | $-38M | $-35M | $-39M | $-46M | $-42M | $-22M | $-34M | $-21M | $-28M | $-17M | $-25M | $-28M | $-45M | $-19M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $18.0K | $19.0K | $29.0K | $107.0K | $-5.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-18.0K | $-17.0K | $-29.0K | $-107.0K | $5.0K | |
| Debt Issued | $0 | $19M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Debt Issued | · | $19M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $141M | $0 | $0 | $0 | $140M | $0 | $0 | $0 | $26M | $-41.0K | $117M | $27M | $1M | $440.0K | $0 | |
| Net Stock Activity | · | $141M | · | · | · | $140M | · | · | · | $26M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $8M | $362M | $187.0K | $0 | $166.0K | $140M | $155.0K | $-53.0K | $210.0K | $64M | $41.0K | $117M | $56M | $1M | $639.0K | $-1.0K | |
| Net Change in Cash | $-33M | $316M | $-36M | $-36M | $-38M | $95M | $-42M | $-22M | $-34M | $43M | $-28M | $100M | $31M | $-26M | $-30M | $-34M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M | · | · | · | $-28M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-22M | · | · | · | · | · | · |
Kârlılık 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -63.6% | 21.4% | · | -54.8% | -13.4% | -5.7% | · | -14.1% | -15.6% | -14.6% | · | -12.8% | -12.6% | -10.9% | · | -16.4% | |
| ROE | -205.4% | 34.9% | · | -119.4% | -19.8% | -7.9% | · | -17.2% | -19.4% | -16.7% | · | -14.9% | -14.5% | -11.5% | · | -18.9% | |
| ROIC | -38.8% | -11.4% | · | -58.8% | -22.3% | -22.4% | · | -21.8% | -19.2% | -15.0% | · | -13.5% | -19.8% | -19.8% | · | -13.2% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 3.3 | · | 1.2 | 8.8 | 10.2 | · | 8.9 | 12.0 | 15.2 | · | 18.6 | 15.2 | 14.9 | · | 7.4 | |
| Quick Ratio | 1.2 | 3.0 | · | 0.9 | 7.1 | 8.7 | · | 7.9 | 10.4 | 13.5 | · | 16.2 | 11.6 | 10.4 | · | 5.9 | |
| Debt / Equity | 0.6 | 0.2 | · | 0.8 | 0.2 | 0.2 | · | 0.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.2 | · | 0.5 | 0.1 | 0.1 | · | 0.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.1 | · | -31.5 | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-339M | $-103M | · | $-232M | $-133M | $-130M | · | $-145M | $-135M | $-121M | · | $-104M | $-92M | $-85M | · | $-76M | |
| Market Cap | $1.92B | $746M | · | $550M | $262M | $266M | · | $431M | $413M | $569M | · | · | · | · | · | · | |
| Enterprise Value | $1.54B | $331M | · | $395M | $71M | $36M | · | $252M | · | · | · | · | · | · | · | · | |
| P/E | -3.5 | -2.3 | · | -2.2 | -1.6 | -1.5 | · | -2.7 | -0.0 | -0.0 | · | -0.0 | -0.0 | -5.0 | · | -5.9 | |
| P/B | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Cash Flow | · | -15.6 | · | · | · | -5.8 | · | · | · | -27.3 | · | · | · | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -27.3 | · | · | · | · | · | · | |
| EV / EBITDA | -29.4 | -7.7 | · | -9.8 | -1.7 | -0.7 | · | -5.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -28.5% | -43.2% | · | -46.2% | -63.2% | -66.8% | · | -37.1% | -10294.4% | -7473.4% | · | -8401.0% | -7506.0% | -20.1% | · | -16.9% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-288M | $-155M | $-118M | $-92M | $-72M |
| Seyreltilmiş Hisse Başı Kâr | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -0.6 | 0.2 | — | — | — |
| Cari Oran | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 |
| Cari Oran | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | $-119M | $-97M | $-106M | $-68M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 250 dosya · $1.3B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 66 (+6 önceki Ç'ye göre) | 30 (+7 önceki Ç'ye göre) | 77 (+3 önceki Ç'ye göre) | 53 (+26 önceki Ç'ye göre) | -2.0M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Deep Track Capital, LP | $172.085.168 | 12.161.496 | 13,73% | Hisse senetleri |
| RTW INVESTMENTS, LP | $151.418.782 | 10.700.974 | 12,08% | Hisse senetleri |
| BIT Capital GmbH | $89.835.478 | 6.348.797 | 7,17% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $70.750.000 | 5.000.000 | 5,65% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $63.257.363 | 4.470.485 | 5,05% | Hisse senetleri |
| ARK Investment Management LLC | $48.845.310 | 3.451.965 | 3,90% | Hisse senetleri |
| Point72 Asset Management, L.P. | $37.085.424 | 2.620.878 | 2,96% | Hisse senetleri |
| Logos Global Management LP | $31.837.500 | 2.250.000 | 2,54% | Hisse senetleri |
| Eagle Health Investments LP | $29.155.042 | 2.060.427 | 2,33% | Hisse senetleri |
| DAFNA Capital Management LLC | $28.469.121 | 2.011.952 | 2,27% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $28.339.691 | 2.002.805 | 2,26% | Hisse senetleri |
| Caption Management, LLC | $27.544.390 | 1.946.600 | 2,20% | Alım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $26.855.285 | 1.897.900 | 2,14% | Alım opsiyonu |
| NEXTBio Capital Management LP | $25.126.990 | 1.775.759 | 2,00% | Hisse senetleri |
| MARSHALL WACE, LLP | $20.935.350 | 1.479.530 | 1,67% | Hisse senetleri |
| Aisling Capital Management LP | $20.267.554 | 1.432.336 | 1,62% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $20.261.229 | 1.431.889 | 1,62% | Hisse senetleri |
| Candriam S.C.A. | $18.013.686 | 1.274.278 | 1,44% | Hisse senetleri |
| Woodline Partners LP | $15.366.957 | 1.086.004 | 1,23% | Hisse senetleri |
| Jefferies Financial Group Inc. | $14.070.661 | 994.393 | 1,12% | Hisse senetleri |
| Trexquant Investment LP | $12.171.236 | 860.158 | 0,97% | Hisse senetleri |
| Kalehua Capital Management LLC | $11.598.642 | 819.692 | 0,93% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $10.909.466 | 770.987 | 0,87% | Hisse senetleri |
| Caption Management, LLC | $10.699.041 | 756.116 | 0,85% | Hisse senetleri |
| Eversept Partners, LP | $9.520.474 | 672.825 | 0,76% | Hisse senetleri |
| Propel Bio Management, LLC | $8.109.167 | 573.086 | 0,65% | Hisse senetleri |
| Creek Drive Management Group LLC | $8.093.800 | 572.000 | 0,65% | Hisse senetleri |
| Occam Crest Management LP | $7.739.000 | 710.000 | 0,62% | Hisse senetleri |
| CITADEL ADVISORS LLC | $7.567.420 | 534.800 | 0,60% | Alım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.140.090 | 504.600 | 0,57% | Satım opsiyonu |
| SILVERARC CAPITAL MANAGEMENT, LLC | $7.122.855 | 503.382 | 0,57% | Hisse senetleri |
| JANE STREET GROUP, LLC | $7.075.821 | 500.058 | 0,56% | Hisse senetleri |
| Qube Research & Technologies Ltd | $7.070.415 | 499.676 | 0,56% | Hisse senetleri |
| Walleye Capital LLC | $6.893.385 | 487.165 | 0,55% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $6.716.340 | 474.653 | 0,54% | Hisse senetleri |
| Blue Owl Capital Holdings LP | $6.367.500 | 450.000 | 0,51% | Hisse senetleri |
| AdvisorShares Investments LLC | $5.962.060 | 421.347 | 0,48% | Hisse senetleri |
| CITADEL ADVISORS LLC | $5.952.679 | 420.684 | 0,47% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $5.909.850 | 856.500 | 0,47% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $5.540.956 | 391.587 | 0,44% | Hisse senetleri |
| HighVista Strategies LLC | $5.251.349 | 371.120 | 0,42% | Hisse senetleri |
| Legal & General Group Plc | $4.700.154 | 332.206 | 0,38% | Hisse senetleri |
| Sumitomo Mitsui Trust Group, Inc. | $4.573.407 | 323.209 | 0,36% | Hisse senetleri |
| Amova Asset Management Americas, Inc. | $4.517.334 | 319.472 | 0,36% | Hisse senetleri |
| Squadron Capital Management LLC | $4.315.750 | 305.000 | 0,34% | Alım opsiyonu |
| Affinity Asset Advisors, LLC | $4.261.739 | 301.183 | 0,34% | Hisse senetleri |
| SEVEN GRAND MANAGERS, LLC | $4.245.000 | 300.000 | 0,34% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.245.000 | 300.000 | 0,34% | Hisse senetleri |
| Squadron Capital Management LLC | $4.245.000 | 300.000 | 0,34% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $4.081.271 | 288.429 | 0,33% | Hisse senetleri |
| JANE STREET GROUP, LLC | $4.079.445 | 288.300 | 0,33% | Alım opsiyonu |
| STEMPOINT CAPITAL LP | $4.029.481 | 284.769 | 0,32% | Hisse senetleri |
| TORONTO DOMINION BANK | $3.930.233 | 277.755 | 0,31% | Hisse senetleri |
| ROYCE & ASSOCIATES LP | $3.778.885 | 267.059 | 0,30% | Hisse senetleri |
| PFM Health Sciences, LP | $3.503.384 | 247.589 | 0,28% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $3.408.367 | 240.874 | 0,27% | Hisse senetleri |
| Brown University | $3.030.930 | 214.200 | 0,24% | Hisse senetleri |
| MORGAN STANLEY | $2.973.693 | 210.155 | 0,24% | Hisse senetleri |
| Caption Management, LLC | $2.950.275 | 208.500 | 0,24% | Satım opsiyonu |
| HEIGHTS CAPITAL MANAGEMENT, INC | $2.913.938 | 205.932 | 0,23% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.695.575 | 190.500 | 0,22% | Satım opsiyonu |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2.481.528 | 175.373 | 0,20% | Hisse senetleri |
| Engineers Gate Manager LP | $2.432.343 | 171.897 | 0,19% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $2.378.474 | 168.090 | 0,19% | Hisse senetleri |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $2.122.500 | 150.000 | 0,17% | Hisse senetleri |
| Squarepoint Ops LLC | $1.962.195 | 138.671 | 0,16% | Hisse senetleri |
| Balyasny Asset Management L.P. | $1.959.492 | 138.480 | 0,16% | Hisse senetleri |
| ALPS ADVISORS INC | $1.930.937 | 136.462 | 0,15% | Hisse senetleri |
| Founders Fund VII Management, LLC | $1.924.272 | 278.880 | 0,15% | Hisse senetleri |
| K2 PRINCIPAL FUND, L.P. | $1.911.665 | 135.100 | 0,15% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $1.897.246 | 134.081 | 0,15% | Hisse senetleri |
| CenterBook Partners LP | $1.777.155 | 125.594 | 0,14% | Hisse senetleri |
| Creek Drive Management Group LLC | $1.698.000 | 120.000 | 0,14% | Alım opsiyonu |
| BANK OF MONTREAL /CAN/ | $1.686.991 | 119.222 | 0,13% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $1.639.118 | 115.839 | 0,13% | Hisse senetleri |
| Palo Alto Investors LP | $1.635.966 | 115.616 | 0,13% | Hisse senetleri |
| Simplify Asset Management Inc. | $1.617.076 | 114.281 | 0,13% | Hisse senetleri |
| LPL Financial LLC | $1.550.387 | 109.568 | 0,12% | Hisse senetleri |
| GROUP ONE TRADING LLC | $1.390.917 | 98.298 | 0,11% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $1.341.448 | 94.802 | 0,11% | Hisse senetleri |
| CreativeOne Wealth, LLC | $1.336.312 | 94.439 | 0,11% | Hisse senetleri |
| STABLEFORD CAPITAL II LLC | $1.300.003 | 91.873 | 0,10% | Hisse senetleri |
| STATE STREET CORP | $1.150.098 | 81.279 | 0,09% | Hisse senetleri |
| Lion Point Capital, LP | $1.132.000 | 80.000 | 0,09% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $1.063.896 | 75.187 | 0,08% | Hisse senetleri |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $1.016.635 | 71.847 | 0,08% | Hisse senetleri |
| DLD Asset Management, LP | $990.500 | 70.000 | 0,08% | Satım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $941.852 | 66.562 | 0,08% | Hisse senetleri |
| Aquatic Capital Management LLC | $922.297 | 65.180 | 0,07% | Hisse senetleri |
| JANE STREET GROUP, LLC | $915.505 | 64.700 | 0,07% | Satım opsiyonu |
| Dorsey Wright & Associates | $883.653 | 62.449 | 0,07% | Hisse senetleri |
| Campbell & CO Investment Adviser LLC | $874.696 | 61.816 | 0,07% | Hisse senetleri |
| STIFEL FINANCIAL CORP | $855.639 | 60.469 | 0,07% | Hisse senetleri |
| Intellectus Partners, LLC | $841.925 | 59.500 | 0,07% | Hisse senetleri |
| DCF Advisers, LLC | $767.638 | 54.250 | 0,06% | Hisse senetleri |
| CIBC WORLD MARKET INC. | $737.357 | 52.110 | 0,06% | Hisse senetleri |
| NATIONAL BANK OF CANADA /FI/ | $731.420 | 51.727 | 0,06% | Hisse senetleri |
| FLAX POND CAPITAL, LLC | $728.951 | 51.516 | 0,06% | Hisse senetleri |
| EXCHANGE TRADED CONCEPTS, LLC | $708.943 | 50.102 | 0,06% | Hisse senetleri |
| PEAK6 LLC | $707.500 | 50.000 | 0,06% | Alım opsiyonu |
Şirket yöneticileri 9 içeriden öğrenenler · 0 yöneticiler · 0 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Kabir Nath | — | 03 Ağustos 2026 F | 361.028 | 0 | 0 | $0 |
| Robert Mcquade | — | 27 Mayıs 2026 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | — | 27 Mayıs 2026 A | — | 0 | 0 | $0 |
| Daphne Karydas | — | 27 Mayıs 2026 A | — | 0 | 0 | $0 |
| Justin D. Gover | — | 27 Mayıs 2026 A | — | 0 | 0 | $0 |
| David Y Norton | — | 27 Mayıs 2026 A | — | 0 | 0 | $0 |
| Wayne Joseph Riley | — | 27 Mayıs 2026 A | — | 0 | 0 | $0 |
| Gino Santini | — | 27 Mayıs 2026 A | — | 0 | 0 | $0 |
| Jeffrey M Jonas | — | 27 Mayıs 2026 A | — | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| AtaiBeckley Inc. | 17 Şubat 2026 | 4,96% | Değişiklik | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 6 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2,43% | 3.316.076 NS | 30 Nisan 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,99% | 40.950 NS | 30 Nisan 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 7.246 SH | 08 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,11% | 797.974 SH | 08 Ağustos 2026 | Günlük |
| BIB · ProShares Trust | 0,06% | 3.487 NS | 31 Mayıs 2026 | N-PORT |
| APIE · Trust for Professional Managers | 0,03% | 21.455 NS | 31 Mayıs 2026 | N-PORT |